CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Novartis-partnered biotech gets $150M Series B to move into the clinic

Positive
AI Analysis

Summary

Matchpoint Therapeutics, partnered with Novartis, secured $150 million in Series B funding to advance its lead program into human clinical trials.

Importance:5/10
Sentiment:
0.60
Series B financingclinical developmentpartnershipcapital raise
Related Companies

Read the original article

Published by Endpoints News on October 7, 2026 2:03 PM

Read Original